For many people in that situation, Roth conversions are the solution. Simply move funds out of a traditional retirement ...

The drugmaker hasn't said its last word yet, as the weight-loss drug battle continues to heat up.

Rivian is on the verge of launching its R2 vehicle, but in the long term, it also hopes to sell its technology to other ...

Utility stocks are often considered slow-growth, defensive plays for turbulent markets. Yet over the past few years, the ...

Chevron, one of the world's largest integrated companies, is a classic dividend stock that pays a forward yield of 3.6% and ...

These two digital advertising platforms are posting record engagement, but the market is heavily focused on near-term ...

It fits right into the company's strategy to establish itself as a differentiated financial services platform.

Viking Therapeutics has a shot at becoming a leader in the weight-loss market. However, the company's quest could run into ...

SpaceX is expected to go public soon, with a valuation of $1.75 trillion. Even if the initial filings occur today, it will be ...

Turning Point Brands' stock had soared on the back of its fast-growing nicotine pouch brands, led by Fre cans. Revenue from ...

Buying leveraged ETFs -- especially in tech stocks -- can bring bigger potential gains, but also bigger risks of loss.

When your employer doesn't offer a 401 (k) or another workplace retirement plan, it can feel like an IRA is your only option.